Glimperide & Metformin Combinations

Get a Price/Quote

Glimperide & Metformin Combinations Specification

Drug Type
Specific Drug

Ingredients
Euroglip-M1: Glimperide 1 mg & Metformin 500 mg Euroglip-M2: Glimperide 2 mg & Metformin 500 mg Euroglip-Plus M2: Glimperide 2 mg & Metformin 1000 mg

Physical Form
Tablets

Function
Other

Recommended For
Management of Type 2 diabetes (NIDDM)

Suitable For
Adults, Aged Person

Glimperide & Metformin Combinations Trade Information

Payment Terms
Cheque, Western Union, Paypal, Cash Advance (CA), Cash in Advance (CID)

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Blister Pack, 20 X 10= 200 TABS

Main Export Market(s)
Western Europe, Central America, Eastern Europe, Middle East, South America, Asia, North America, Australia, Africa

Main Domestic Market
All India

Certifications
WHO-GMP

About Glimperide & Metformin Combinations

Glimperide & Metformin Combinations are formulated to aid in the effective management of Type 2 diabetes mellitus (NIDDM). The tablets combine two potent active ingredients: Glimperide, a sulfonylurea that stimulates insulin release from the pancreas, and Metformin, a biguanide that improves insulin sensitivity and reduces glucose production in the liver. Available in multiple formulations tailored to varying medical needs, Euroglip-M1 contains Glimperide 1 mg and Metformin 500 mg, Euroglip-M2 incorporates Glimperide 2 mg and Metformin 500 mg, and Euroglip-Plus M2 delivers Glimperide 2 mg and Metformin 1000 mg. These tablets are manufactured for adults and aged persons, ensuring precise and reliable performance for diabetes management. Designed for export, these specific drug products meet stringent quality standards suitable for both patients and healthcare providers.